Sort
78,016 grants matching “breast cancer”
Multi-Spectral Parallel-Plate Diffuse Optical Breast Tomography
$444,568Arjun G. Yodh · University Of Pennsylvania · R01 · FY2012 · EB
Mechanism of p53-dependent Tumor Suppression
$444,566Xinbin Chen · University Of California At Davis · R01 · FY2023 · CA
Targeting vulnerabilities in copper metabolism in the development of cancer therapies
$444,564Michael J Petris · University Of Missouri-Columbia · R01 · FY2022 · CA
Targeting the Cancer Glycocalyx
$444,498Carolyn R Bertozzi · Stanford University · R01 · FY2019 · CA
INTERVENTION DEVELOPMENT AND MEASUREMENT
$444,487Suzanne M Miller · University Of Colorado Denver · P01 · FY2009 · CA
An innate immune checkpoint in cancer immunotherapy
$444,441Carla Rothlin · Yale University · R01 · FY2019 · CA
Comprehensive minimal residual disease tracking in cancer
$444,440G. Mike Makrigiorgos · Dana-Farber Cancer Inst · R01 · FY2025 · CA
A GIS Based Workbench to Interpret Cancer Maps
$444,421University Of Iowa · R01 · FY2002 · CA
THERAPEUTIC BENEFIT OF POTASSIUM CHANNEL ACTIVATORS IN TRIPLE-NEGATIVE BREAST CANCER
$444,416University Of Illinois · · FY2020 · Defense Health Agency
FAMILY HOME CARE FOR CANCER--A COMMUNITY BASED MODEL
$444,395Michigan State University · R01 · FY2001 · CA
Commercial Prototype of Optoacoustic Breast Imager
$444,370Fairway Medical Technologies, Inc. · R44 · FY2005 · CA
PKC Alpha as a Marker for Logical Therapeutic Approaches to Breast Cancer
$444,344Debra Tonetti · University Of Illinois At Chicago · R01 · FY2007 · CA
PI3K/PTEN/Akt signaling and the genesis of cancer
$444,339Nissim Hay · University Of Illinois At Chicago · R01 · FY2024 · CA
Fatty Acid Synthase:Molecular Target for Breast Cancer Therapy & Chemoprevention
$444,316Ruth Lupu · Mayo Clinic Rochester · R01 · FY2009 · CA
Metabolic adaptation in residual triple negative breast cancer following chemotherapy
$444,306Gloria Vittone Echeverria · Baylor College Of Medicine · R37 · FY2023 · CA
The role of DNA damage tolerance pathways in human cells
$444,297Anja-Katrin Bielinsky · University Of Minnesota · R01 · FY2020 · GM
The role of DNA damage tolerance pathways in human cells
$444,297Anja-Katrin Bielinsky · University Of Minnesota · R01 · FY2021 · GM
Activity of Nuclear Receptor Coregulators with Chromatin
$444,274William L Kraus · Ut Southwestern Medical Center · R01 · FY2019 · DK
Activity of Nuclear Receptor Coregulators with Chromatin
$444,274William L Kraus · Ut Southwestern Medical Center · R01 · FY2020 · DK
Dynamic Imaging for EMT in Breast Cancer Microenvironment
$444,273Christopher H Contag · Michigan State University · R01 · FY2017 · CA
Dissecting Mechanisms of Metastasis Through Comparative Systems Genetics
$444,268David G Kirsch · Duke University · R01 · FY2011 · CA
(PQ6) Molecular Mechanisms Driving Benign to Malignant Transitions in Breast Cancer
$444,234Anna Tate Riegel · Georgetown University · R01 · FY2019 · CA
Calorie restriction and aging
$444,211Rafael De Cabo · National Institute On Aging · ZIA · FY2025 · AG
Enhancing cognitive function in breast cancer survivors through community-based aerobic exercise training
$444,206Diane Kristen Ehlers · Mayo Clinic Arizona · R37 · FY2022 · CA
GENETIC MECHANISMS OF BREAST TUMOR PROGRESSION
$444,205Southern Research Institute · R01 · FY2001 · CA